Home
/ Moderna
/ Competitors

Moderna Competitors and Similar CompaniesClear all

Moderna's competitors and similar companies include CureVac, Regulus Therapeutics, Alnylam Pharmaceuticals, Celyad and Sarepta Therapeutics.

	Moderna Moderna is a biotechnology company that develops therapeutics and vaccines.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	Regulus Therapeutics Regulus Therapeutics is a biopharmaceutical company involved in the R&D of high-impact medicines based on microRNAs.	Alnylam Pharmaceuticals Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.	Celyad Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.	Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Founding Date	Founding Date 2010	Founding Date 2000	Founding Date 2007	Founding Date 2002	Founding Date 2007	Founding Date 1980
Type	Type Public	Type Public	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech clinical research drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech drug development genetics
Locations	Locations Cambridge, US HQ Norwood, US	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations San Diego, US HQ	Locations Cambridge, US HQ Paris, FR Milan, IT Tokyo, JP Amsterdam, NL Stockholm, SE Zug, CH see more	Locations Mont-Saint-Guibert, BE HQ New York, US	Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US
Employees	Employees 2,700108% increase	Employees 1,04962% increase	Employees 2462% decrease	Employees 1,32324% increase	Employees 3563% decrease	Employees 8403% decrease
Valuation ($)	Valuation ($) 30.4 b	Valuation ($) 1.2 b	Valuation ($) 26.3 m	Valuation ($) 20 b	Valuation ($) 22.7 m	Valuation ($) 7.6 b
Twitter followers	Twitter followers 151.2 k	Twitter followers 12	Twitter followers 790	Twitter followers 16.3 k	Twitter followers 2.4 k	Twitter followers 5 k
Number of tweets (last 30 days)	Number of tweets (last 30 days) 17	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) N/A	Number of tweets (last 30 days) 23	Number of tweets (last 30 days) 2	Number of tweets (last 30 days) 13
Average likes per tweet (last 30 days)	Average likes per tweet (last 30 days) 39.6	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) N/A	Average likes per tweet (last 30 days) 3	Average likes per tweet (last 30 days) 1	Average likes per tweet (last 30 days) 40.6
Percentage of tweets with engagement (last 30 days)	Percentage of tweets with engagement (last 30 days) 100%	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) N/A	Percentage of tweets with engagement (last 30 days) 86.96%	Percentage of tweets with engagement (last 30 days) 50%	Percentage of tweets with engagement (last 30 days) 69.23%
Employee Rating	Employee Rating 3.7	Employee Rating 3.2	Employee Rating 2.8	Employee Rating 4.2	Employee Rating 3.5	Employee Rating 4.1
Financial
Revenue (est.)	Revenue (est.) $19.3b (FY, 2022)	Revenue (est.) €67.4m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $1b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $933m (FY, 2022)
Cost of goods	Cost of goods $5.4b (FY, 2022)	Cost of goods €93.2m (FY, 2022)	Cost of goods N/A	Cost of goods $140.2m (FY, 2022)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $13.8b (FY, 2022)	Gross profit €12.1m (FY, 2022)	Gross profit N/A	Gross profit $897.2m (FY, 2022)	Gross profit €24.1m (FY, 2022)	Gross profit N/A
Net income	Net income $8.4b (FY, 2022)	Net income (€249m) (FY, 2022)	Net income ($28.3m) (FY, 2022)	Net income ($1.1b) (FY, 2022)	Net income (€40.9m) (FY, 2022)	Net income ($703.5m) (FY, 2022)
Operating ⚠
Patent Applications	Patent Applications 430 (FY, 2021)	Patent Applications 500 (Mar, 2020)	Patent Applications N/A	Patent Applications N/A	Patent Applications N/A	Patent Applications N/A
Patents Issued	Patents Issued 270 (FY, 2020)	Patents Issued 233 (May, 2020)	Patents Issued 300 (FY, 2016)	Patents Issued N/A	Patents Issued N/A	Patents Issued N/A
Funding
Total funding raised	Total funding raised $ 1.8b	Total funding raised $ 1.1b	Total funding raised $ 10m	Total funding raised $ 1.5b	Total funding raised N/A	Total funding raised N/A